Creating a data system to study cancer treatments using dogs
Development of an Integrated Canine Data Commons (ICDC)
This study is looking at how we can use information from dogs with cancer to help find better treatments for people with cancer, making it easier and faster to test new drugs that could work for both dogs and humans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10934477 on NIH RePORTER |
What this research studies
This research aims to develop an integrated data commons that utilizes naturally occurring cancers in dogs to evaluate new cancer therapies. By leveraging the similarities between canine and human cancers, the project will aggregate data from canine clinical trials to identify promising drug combinations for human use. The approach addresses the overwhelming number of new drugs needing evaluation by prioritizing the most effective treatments based on real-world canine data. This innovative methodology seeks to enhance the efficiency of clinical trials and improve cancer treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with various types of cancer who may benefit from novel therapeutic approaches.
Not a fit: Patients with rare or highly specific cancer types that do not have corresponding canine models may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective cancer treatments for humans by utilizing data from canine cancer cases.
How similar studies have performed: Previous research has shown promise in using canine models to inform human cancer treatments, indicating that this approach has potential for success.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Otridge, John — Leidos Biomedical Research, INC.
- Study coordinator: Otridge, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.